论文部分内容阅读
目的:探讨联合应用盐酸氨溴索和布地奈德对支气管肺炎患儿进行治疗的临床价值。方法:随机选取2015年6月至2016年8月佛山市南海经济开发区人民医院收治的58例支气管肺炎患儿分为对照组、观察组,分别给予布地奈德气雾剂、布地奈德+盐酸氨溴索雾化吸入治疗,对比2组患儿治疗效果。结果:观察组治疗总有效率(93.10%)显著高于对照组(79.31%),不良反应发生率显著低于对照组;观察组患儿相关症状消失平均时间、住院时间均显著短于对照组,组间对比,差异具有统计学意义(P<0.05)。结论:联合应用布地奈德和盐酸氨溴索对支气管肺炎患儿进行雾化吸入治疗,能够取得更加确切的治疗效果,促进患儿得到更快康复。
Objective: To investigate the clinical value of ambroxol hydrochloride combined with budesonide in the treatment of children with bronchial pneumonia. Methods: Fifty-eight children with bronchopneumonia admitted to People’s Hospital of Nanhai Economic Development Zone in Foshan City from June 2015 to August 2016 were randomly divided into control group and observation group. Budesonide aerosol, budesonide + Hydrochloride ambroxol inhalation therapy, compared with two groups of children with treatment. Results: The total effective rate (93.10%) in the observation group was significantly higher than that in the control group (79.31%), the incidence of adverse reactions was significantly lower than that in the control group. The mean disappearance time and hospital stay in the observation group were significantly shorter than those in the control group , The difference between groups was statistically significant (P <0.05). Conclusion: Combined use of budesonide and ambroxol hydrochloride for inhalation of bronchial pneumonia in children can achieve more accurate treatment and promote faster recovery in children.